Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Buy
15,221
+578
+4% +$67.7K 0.16% 76
2026
Q1
$1.76M Buy
14,643
+1,401
+11% +$162K 0.16% 77
2025
Q4
$1.39M Sell
13,242
-509
-4% -$47.8K 0.11% 87
2025
Q3
$1.15M Buy
13,751
+1,043
+8% +$85.9K 0.09% 105
2025
Q2
$1.01M Buy
12,708
+87
+0.7% +$6.92K 0.09% 106
2025
Q1
$1.13M Sell
12,621
-1,524
-11% -$142K 0.11% 92
2024
Q4
$1.41M Buy
14,145
+1,109
+9% +$114K 0.14% 59
2024
Q3
$1.28M Buy
13,036
+8,751
+204% +$1.04M 0.12% 69
2024
Q2
$530K Buy
4,285
+1,744
+69% +$225K 0.06% 105
2024
Q1
$335K Buy
+2,541
New +$313K 0.08% 100

Other funds holding MRK

LRI Investments's MRK Position: Q2 2026 in Review

LRI Investments increased its Merck (MRK) stake by 3.9% in Q2 2026, buying an estimated $67.7K and bringing the position to 15,221 shares worth $1.96M. The position accounts for 0.16% of the portfolio, ranked #76.

LRI Investments first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. 1,779 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • LRI Investments held 15,221 shares of Merck worth $1.96M as of Q2 2026.
  • LRI Investments bought 578 Merck shares in Q2 2026, an estimated $67.7K.
  • Merck made up 0.16% of LRI Investments's portfolio in Q2 2026, its #76 holding.
  • LRI Investments first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • 1,779 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.